May 13, 2021
…Diego’s Head and Neck Cancer Center Hanna and Mark Gleiberman have embraced philanthropic endeavors supporting UC San Diego and the San Diego community. Most recently, the couple has made a $12 million gift to support the newly named Hanna and Mark Gleiberman Head and Neck Cancer Center at UC San…
September 23, 2024
…and Legends of Surfing Invitational to raise funds for research at Moores Cancer Center at UC San Diego Health. With 16 surf teams, the invitational was filled with energy and camaraderie. The event has raised $12 million for cancer research since it was established.
September 14, 2023
University of California San Diego School of Medicine’s Napoleone Ferrara, MD, has been named a 2023 Keio Medical Science Prize Laureate. Awarded annually by Keio University, Japan’s oldest private university, the award recognizes outstanding achievements in medicine and life sciences.
June 22, 2020
UC San Diego researchers uncovered in mice how IRE1α, a molecule involved in cells’ response to stress, determines whether macrophages promote inflammation in the tumor microenvironment. Inflammation is known to promote tumor growth, making IRE1α an attractive target for drug development.
December 7, 2021
UC San Diego researchers identify new strategy to improve efficacy of immunotherapy on resistant liver cancers.
August 22, 2018
Christopher Kane, MD, has been appointed dean of clinical affairs for UC San Diego School of Medicine and CEO of UC San Diego Health Physicians, effective July 15. In these dual roles, Kane will collaborate with UC San Diego leadership to ensure that UC San Diego Health Physicians achieve the…
March 27, 2023
Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health examined a new treatment approach for endometrial cancer.
January 22, 2015
Upending decades-old dogma, a team of scientists at the University of California, San Diego School of Medicine say enzymes long categorized as promoting cancer are, in fact, tumor suppressors and that current clinical efforts to develop inhibitor-based drugs should instead focus on restoring the enzymes’ activities.
July 21, 2016
…expand the number of cancer gene mutations that can be specifically targeted with personalized therapies, researchers at University of California San Diego School of Medicine and Moores Cancer Center looked for combinations of mutated genes and drugs that together kill cancer cells. The study, published July 21 in Molecular Cell,…
October 2, 2014
…with the deadly skin cancer at age 37. Today, it is still the only 5K dedicated to raising funds for melanoma research in San Diego. The event has grown exponentially over the past two decades, garnering over $1.3 million to support melanoma research, treatment and education at UC San Diego…
